News Search

Category: Industry Trends

Philadelphia Ranks Second in New Study Comparing U.S. Cell and Gene Therapy Hubs

Philadelphia ranks second in a newly released study comparing 14 U.S. cell and gene therapy hubs in five key categories.

Five Philadelphia Organizations Are Partnering for a New Biotech Technician Training Program Starting this Fall

Five organizations will partner for a paid workforce development training program called Biomedical Technician Training Program: Aseptic Manufacturing.

Philadelphia Innovation Hub Experiences Explosive Growth in Manufacturing, Research and Talent

Philadelphia's innovation hub has seen explosive growth over the past several years, with significant expansions in manufacturing and research space for multiple companies.

Cell and Gene Therapy On Track to Hit Record Number of Regulatory Approvals; Potential Implications for Commercial Real Estate Industry

While the CGT industry is growing at a rapid rate, real estate development happens much slower, which may have implications for the amount of available space.

Penn Medicine Ranks on List of Top US Health Systems by Merative and Fortune

Penn Medicine ranked number two out of the top five large health systems, second only to Mayo Clinic in Rochester, MN. 

Philadelphia-based Cancer Research Institutions Receive over $700M in National Cancer Institute Grants from 2019 to 2021, Fourth-most in the Nation

The University of Pennsylvania led the region with 490 NCI grants totaling $234 million during this three year time period.

Philadelphia Ranked as One of the Top Startup Ecosystems in the United States

Startup Genome described Philly as "a vibrant Life Science hub and a particularly attractive home base for female entrepreneurs." 

Philadelphia Cell and Gene Therapy Jobs More Than Doubled in Less Than Three Years

As the number of gene and cell therapy jobs continue to grow, Philadelphia continues to attract diverse pools of talent.

Pharma Companies Search for Solutions in the Face of Upcoming Patent Cliff

Read about the current state of the biopharma industry in the face of pending patent cliff.

Filter

Skip to content